MR Imaging in Monitoring and Predicting Treatment Response in Multiple Sclerosis

Jordi Río, Cristina Auger, Àlex Rovira

Research output: Contribution to journalReview articleResearchpeer-review

17 Citations (Scopus)


© 2017 Elsevier Inc. MR imaging is the most sensitive tool for identifying lesions in patients with multiple sclerosis (MS). MR imaging has also acquired an essential role in the detection of complications arising from these treatments and in the assessment and prediction of efficacy. In the future, other radiological measures that have shown prognostic value may be incorporated within the models for predicting treatment response. This article examines the role of MR imaging as a prognostic tool in patients with MS and the recommendations that have been proposed in recent years to monitor patients who are treated with disease-modifying drugs.
Original languageEnglish
Pages (from-to)277-287
JournalNeuroimaging Clinics of North America
Issue number2
Publication statusPublished - 1 May 2017


  • Interferon
  • MR imaging
  • Multiple sclerosis
  • Patient assessment
  • Relapsing-remitting multiple sclerosis
  • Scoring system
  • Treatment response


Dive into the research topics of 'MR Imaging in Monitoring and Predicting Treatment Response in Multiple Sclerosis'. Together they form a unique fingerprint.

Cite this